Giant cell arteritis (GCA) is the most frequent primary systemic vasculitis in adults, involving medium-to-large-sized ...

SHREVEPORT, La. - Giant cell arteritis, also known as temporal arteritis, is a less common condition where people get inflammation of the arteries that go to the head and neck.

However, the pain is caused by other headaches and conditions, such as tension headaches, migraines, temporal arteritis, infections, and jaw problems. The best treatment depends on the cause of ...

Roche/Chugai’s RoActemra has now won the backing of the National Institute of Health and Care Excellence for the treatment of eligible patients with giant cell arteritis (GCA). Roche/Chugai’s ...

446.5: cranial arteritis, GCA, and temporal arteritis. ... months after a new-onset headache or one that is different from previous headaches. 3,8 GCA headaches mainly affect the temporal region, ...

AbbVie (NYSE:ABBV) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed Upadacitinib as a treatment for giant cell arteritis, an autoimmune ...

The Food and Drug Administration on Monday expanded the approved use of Roche’s arthritis drug, Actemra. Here are three things to know. The FDA first approved Actemra in 2010 as a treatment for ...

Takayasu arteritis is a rare, chronic inflammatory disease that primarily affects the aorta and its main branches. It is a form of vasculitis. Learn more here.

“Giant-Cell Arteritis Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenario and growth prospects across the Giant-Cell ...

KIAWAH ISLAND, S.C. — Temporal artery ultrasound and EULAR score are reliable means for diagnosing giant cell arteritis, Mercy Bechtold, MD, said during her presentation at Kiawah Eye.